Skip to main content
TipRanks
Go Ultimate75% OFF

Kanishka Das Profile - Zacks Equity Research Blogger

4 Followers

Kanishka Das's Stock Coverage

MRK
Merck & Company
Nov 19, 2026Neutral6Ratings80%+2.26%
HALO
Halozyme
Nov 17, 2026Neutral1Ratings――
NKTR
Nektar Therapeutics
Oct 15, 2026Neutral2Ratings0%-14.10%
RHHBY
Roche Holding
Oct 14, 2026Bearish1Ratings0%-9.40%
AZN
AstraZeneca
Oct 14, 2026Bearish2Ratings50%-6.55%
BMY
Bristol-Myers Squibb
Oct 14, 2026Bearish1Ratings0%-6.10%
IRWD
Ironwood Pharma
Oct 07, 2026Bullish2Ratings100%+25.70%
ABBV
AbbVie
Oct 07, 2026Bullish1Ratings100%+9.20%
PGEN
Precigen
Sep 30, 2026Bullish4Ratings0%-41.65%
INO
Inovio Pharmaceuticals
Sep 30, 2026Bullish4Ratings100%+14.57%

Disclaimer: TipRanks collects ratings of bloggers by scanning publicly available reports on financial websites and by receiving reports directly from the bloggers or from our users. The information displayed might not be accurate or up to date. The displayed ratings are made entirely at the sole discretion of the bloggers. TipRanks holds no liability over the bloggers information or opinions expressed on the site. See how TipRanks ranks experts and calculates performance.